Alliance Pharma (LON:APH) Trading Down 9.1%

Shares of Alliance Pharma plc (LON:APH) traded down 9.1% on Wednesday . The company traded as low as GBX 28 ($0.35) and last traded at GBX 29.10 ($0.37). 1,989,571 shares were traded during trading, an increase of 114% from the average session volume of 930,631 shares. The stock had previously closed at GBX 32 ($0.40).

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reduced their price objective on Alliance Pharma from GBX 65 ($0.82) to GBX 60 ($0.75) and set an “outperform” rating for the company in a research note on Wednesday, January 31st.

Alliance Pharma Trading Down 20.8 %

The business’s 50-day simple moving average is GBX 37.39 and its 200-day simple moving average is GBX 38.24. The company has a market cap of £136.99 million, a PE ratio of -3,200.00, a P/E/G ratio of 1.04 and a beta of 0.60. The company has a current ratio of 1.93, a quick ratio of 1.42 and a debt-to-equity ratio of 45.00.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.